Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.

Saved in:
Bibliographic Details
Title: Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.
Authors: Chapman MJ; Dyslipidemia, Inflammation and Atherosclerosis Research Unit, UMR-S939, National Institute for Health and Medical Research (INSERM), Hôpital de la Pitié-Salpetriere, Paris, France. john.chapman@upmc.fr, Redfern JS, McGovern ME, Giral P
Source: Pharmacology & therapeutics [Pharmacol Ther] 2010 Jun; Vol. 126 (3), pp. 314-45. Date of Electronic Publication: 2010 Feb 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 7905840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-016X (Electronic) Linking ISSN: 01637258 NLM ISO Abbreviation: Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-016X
DOI:10.1016/j.pharmthera.2010.01.008